hoʻāʻo-lapaʻau-cal

ʻO ka maʻi ʻo Crohn (CD) kahi maʻi mumū ʻōpū maʻi ʻole kikoʻī. ʻAʻole maopopo ke kumu o ka maʻi ʻo Crohn, i kēia manawa, pili ia i nā kumu genetic, maʻi, ke kaiapuni a me nā immunologic.

 

I nā makahiki he ʻumi i hala iho nei, ua ulu mau ka nui o ka maʻi o Crohn. Mai ka paʻi ʻia ʻana o ka paʻi mua o nā alakaʻi hana, ua nui nā loli i hana ʻia i ka ʻike a me ka mālama ʻana i nā maʻi me ka maʻi o Crohn. No laila, i ka makahiki 2018, ua hōʻano hou ka American Society of Gastroenterology i ke alakaʻi o ka maʻi o Crohn a hāʻawi i kekahi mau manaʻo no ka ʻike a me ka mālama ʻana, i hoʻolālā ʻia e hoʻoponopono maikaʻi i nā pilikia olakino e pili ana i ka maʻi o Crohn. Manaʻolana ʻia e hiki i ke kauka ke hoʻohui i nā alakaʻi me nā pono, nā makemake a me nā waiwai o ka mea maʻi i ka wā e hana ai i nā hoʻoholo lapaʻau i mea e mālama pono ai i nā maʻi me ka maʻi o Crohn.

 

Wahi a ka American Academy of Gastroenteropathy (ACG): He hōʻailona hoʻāʻo pono ka Fecal calprotectin (Cal), hiki iā ia ke kōkua i ka hoʻokaʻawale ʻana ma waena o ka maʻi ʻōpū mumū (IBD) a me ka maʻi ʻōpū huhū (IBS). Eia kekahi, ua hōʻike ʻia kekahi mau noiʻi e ʻike ka Fecal calprotectin i ka IBD a me ke kanesa colorectal, hiki i ka ʻike o ka ʻike ʻana iā IBD a me IBS ke hiki i 84% -96.6%, hiki i ka kikoʻī ke hiki i 83% -96.3.

E ʻike hou aʻe e pili anaʻO ka calprotectin fecal (Cal).


Ka manawa hoʻouna: ʻApelila-28-2019